The APAC Dialysis Equipment Market Size is forecasted to be worth USD 5.99 billion by 2027 from USD 3.74 billion in 2022, witnessing a CAGR of 9.9% during the forecast period 2022 to 2027.
The exponentially increasing frequency of end-stage renal illness and rising chronic kidney diseases will likely boost the dialysis equipment market. Furthermore, government initiatives and assistance to treat end-stage renal disease and chronic kidney disease propel the dialysis equipment market to new heights. Kidney injury, renal failure, kidney dysfunction, and the removal of excess waste or pollutants from the kidneys are all conditions when dialysis devices are utilized to filter a patient's blood.
In emerging nations, the increased number of hospitals, dialysis centers, and combination therapies will likely boost the regional market growth.
The growing need for dialysis and laboratories is propelling the industry forward even more. Dialysis is an expensive kind of kidney therapy, which is why the dialysis equipment business is flourishing to make renal care more accessible. Dialysis treatment will continue in high demand due to chronic renal disease, aggravated by the aging population and longer life expectancy. Market companies in the region that take advantage of development opportunities also contribute to market growth.
Additionally, increased technology breakthroughs to improve medical services and treatments have an impact on market growth. However, rising awareness of diseases and therapy options is projected to propel the industry forward. The government's increased investment and support in the region have accelerated market expansion.
End-stage renal disease is more common in the elderly population, and their demand for frequent dialysis therapy is exceptionally high. This demographic is propelling the dialysis equipment market forward and stimulating industry innovation.
Market growth is estimated to be hampered by challenges such as a lack of information on the therapy, an increase in demand for new dialysis devices, and concerns about the hazards of dialysis. In addition, over the forecast period, strict regulations, expensive pricing for complex treatments, and a scarcity of experienced experts are predicted to hinder the growth of the renal dialysis equipment market.
This research report on the APAC Dialysis Equipment Market has been segmented and sub-segmented into the following categories:
By Type:
By End-User:
By Country:
The Asia Pacific is the world's fastest-growing regional market, and it is predicted to continue rising at a robust pace. Supportive government measures, higher healthcare expenditure, and expanding technology in the region's healthcare sector are projected to drive market expansion. During the predicted period, China and Japan are expected to have substantial growth.
China dialysis equipment market is anticipated to witness the largest share of the dialysis equipment market. The market growth is attributed to the growing healthcare infrastructure is likely to provide prospects for expansion. In addition, peritoneal dialysis demand is increasing in emerging countries such as China and India, and this trend is expected to continue.
In Japan dialysis equipment market, the dialysis sector brought in a lot of profit. Improved healthcare infrastructure and government assistance would drive the dialysis business.
India dialysis equipment market is expanding the health insurance markets and are boosting the market growth. Furthermore, an aging population and increased home dialysis and peritoneal dialysis use will help market growth. Due to recent industry developments, such as mergers and acquisitions, the Indian market is rapidly expanding. Patients in less developed countries are less likely to have access to advanced therapy; thus, they demand alternatives that utilizes less water and infrastructure as well.
KEY MARKET PLAYERS:
Fresenius Medical, Care AG & Co, Gambro AB, Baxter International Inc, Nipro Inc, ALL-MED Medical GmbH, Asahi Kasei Corporation are a few notable companies in the APAC dialysis equipment market.,
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Hemodialysis Equipment
5.1.2.1 Hemodialysis Machines
5.1.2.2 Dialyzers
5.1.2.3 Blood Access Device Dialysate
5.1.3 Peritoneal Dialysis Equipment
5.1.3.1 Continuous Cycling Peritoneal Dialysis
5.1.3.2 Continuous Ambulatory Peritoneal Dialysis
5.1.3.3 Intermittent Peritoneal Dialysis
5.1.4 Continuous Renal Replacement Therapy Systems
5.1.5 Dialysis Accessories
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.2 End-User
5.3.1 Introduction
5.3.2 In-Center Dialysis
5.3.3 Homecare Dialysis
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of Asia Pacific
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Fresenius Medical Care AG & Co.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Gambro AB
8.3 Baxter International Inc.
8.4 Nipro Inc.
8.5 ALLMED Medical GmbH
8.6 Asahi Kasei Corporation
8.7 Celgene Corporation
8.8 Invitrogen
8.9 Cytori Therapeutics
8.10 Retractable Technologies
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
